Welcome to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
NB: We use cookies to help personalise your web experience and comply with Irish healthcare law. Whatever your choice, you are agreeing to our use of cookies. Please close this browser tab if you don't want to proceed.
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

July 1, 2016

Infective Endocarditis Facts and Figures

Electron micrograph (SEM) of methicillin-resistant Staphylococcus aureus bacteria (MRSA);
Magnification 2363x.


Infective Endocarditis1
  • The prevalence of cardiac device infections in patients with S. aureus bacteremia (SAB) is approximately 50%.
  • The prevalence of infective endocarditis in SAB patients ranges from 11 to 50%.
  • The number of cardiac devices implanted has increased dramatically together with the number of device-related infections.
  • The rates of cardiac rhythm management device infections increase faster than the implant rate.
  • Infective endocarditis has become more difficult to treat due to a high number of MRSA infections and the increasing number of device infections.
  • Strong evidence supports the use of screening with echocardiography in patients with SAB.

=>      European Society of Cardiology guidelines provide a review of the diagnosis, management and treatment of infective endocarditis2.



1-  Rasmussen RV. Future Challenges and Treatment of  Staphylococcus aureus Bacteraemia with Emphasis on MRSA. Future Microbiology. 2011;6(1):43-56.

2- Habib G, Hoen B, Tornos P et al.: Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur. Heart J. 2009; 30(19), 2369–2413.